Logo image of CHCI

COMSTOCK HOLDING COMPANIES (CHCI) Stock Fundamental Analysis

USA - NASDAQ:CHCI - US2056842022 - Common Stock

13.76 USD
+0.4 (+2.99%)
Last: 11/3/2025, 2:55:21 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to CHCI. CHCI was compared to 63 industry peers in the Real Estate Management & Development industry. CHCI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CHCI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

CHCI had positive earnings in the past year.
CHCI had a positive operating cash flow in the past year.
CHCI had positive earnings in each of the past 5 years.
In the past 5 years CHCI always reported a positive cash flow from operatings.
CHCI Yearly Net Income VS EBIT VS OCF VS FCFCHCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

The Return On Assets of CHCI (24.12%) is better than 100.00% of its industry peers.
CHCI's Return On Equity of 28.38% is amongst the best of the industry. CHCI outperforms 98.41% of its industry peers.
CHCI's Return On Invested Capital of 16.04% is amongst the best of the industry. CHCI outperforms 98.41% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CHCI is significantly above the industry average of 6.24%.
Industry RankSector Rank
ROA 24.12%
ROE 28.38%
ROIC 16.04%
ROA(3y)20.05%
ROA(5y)19.74%
ROE(3y)27.08%
ROE(5y)30.75%
ROIC(3y)18.89%
ROIC(5y)16.39%
CHCI Yearly ROA, ROE, ROICCHCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

CHCI has a better Profit Margin (28.35%) than 95.24% of its industry peers.
CHCI's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 20.59%, CHCI belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
CHCI's Operating Margin has improved in the last couple of years.
The Gross Margin of CHCI (25.02%) is comparable to the rest of the industry.
CHCI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 20.59%
PM (TTM) 28.35%
GM 25.02%
OM growth 3Y6.94%
OM growth 5Y17.14%
PM growth 3Y-13.42%
PM growth 5Y51.49%
GM growth 3Y6.26%
GM growth 5Y8.78%
CHCI Yearly Profit, Operating, Gross MarginsCHCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CHCI is creating value.
The number of shares outstanding for CHCI has been increased compared to 1 year ago.
CHCI has more shares outstanding than it did 5 years ago.
There is no outstanding debt for CHCI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CHCI Yearly Shares OutstandingCHCI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CHCI Yearly Total Debt VS Total AssetsCHCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 7.10 indicates that CHCI is not in any danger for bankruptcy at the moment.
CHCI's Altman-Z score of 7.10 is amongst the best of the industry. CHCI outperforms 84.13% of its industry peers.
CHCI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.1
ROIC/WACC1.83
WACC8.75%
CHCI Yearly LT Debt VS Equity VS FCFCHCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

A Current Ratio of 4.26 indicates that CHCI has no problem at all paying its short term obligations.
The Current ratio of CHCI (4.26) is better than 85.71% of its industry peers.
A Quick Ratio of 4.26 indicates that CHCI has no problem at all paying its short term obligations.
The Quick ratio of CHCI (4.26) is better than 90.48% of its industry peers.
Industry RankSector Rank
Current Ratio 4.26
Quick Ratio 4.26
CHCI Yearly Current Assets VS Current LiabilitesCHCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 82.81% over the past year.
The Earnings Per Share has been growing by 61.08% on average over the past years. This is a very strong growth
Looking at the last year, CHCI shows a quite strong growth in Revenue. The Revenue has grown by 18.35% in the last year.
CHCI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.18% yearly.
EPS 1Y (TTM)82.81%
EPS 3Y-1.83%
EPS 5Y61.08%
EPS Q2Q%50.98%
Revenue 1Y (TTM)18.35%
Revenue growth 3Y18.15%
Revenue growth 5Y15.18%
Sales Q2Q%20.64%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHCI Yearly Revenue VS EstimatesCHCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 9.11, which indicates a very decent valuation of CHCI.
CHCI's Price/Earnings ratio is rather cheap when compared to the industry. CHCI is cheaper than 90.48% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.11. CHCI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.11
Fwd PE N/A
CHCI Price Earnings VS Forward Price EarningsCHCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHCI is valued cheaper than 93.65% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CHCI is valued cheaper than 93.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.86
EV/EBITDA 8.86
CHCI Per share dataCHCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

CHCI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.15
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CHCI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

COMSTOCK HOLDING COMPANIES

NASDAQ:CHCI (11/3/2025, 2:55:21 PM)

13.76

+0.4 (+2.99%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-06 2025-08-06
Earnings (Next)11-05 2025-11-05
Inst Owners8.55%
Inst Owner Change0%
Ins Owners66.12%
Ins Owner Change-2.25%
Market Cap138.56M
Revenue(TTM)55.51M
Net Income(TTM)15.74M
Analysts0
Price TargetN/A
Short Float %1.13%
Short Ratio1.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.11
Fwd PE N/A
P/S 2.5
P/FCF 9.86
P/OCF 9.62
P/B 2.5
P/tB 2.51
EV/EBITDA 8.86
EPS(TTM)1.51
EY10.97%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.39
FCFY10.14%
OCF(TTM)1.43
OCFY10.4%
SpS5.51
BVpS5.51
TBVpS5.49
PEG (NY)N/A
PEG (5Y)0.15
Graham Number13.68
Profitability
Industry RankSector Rank
ROA 24.12%
ROE 28.38%
ROCE 20.3%
ROIC 16.04%
ROICexc 34.98%
ROICexgc 35.24%
OM 20.59%
PM (TTM) 28.35%
GM 25.02%
FCFM 25.3%
ROA(3y)20.05%
ROA(5y)19.74%
ROE(3y)27.08%
ROE(5y)30.75%
ROIC(3y)18.89%
ROIC(5y)16.39%
ROICexc(3y)36.53%
ROICexc(5y)31.24%
ROICexgc(3y)36.83%
ROICexgc(5y)32.34%
ROCE(3y)23.91%
ROCE(5y)20.74%
ROICexgc growth 3Y10.99%
ROICexgc growth 5Y13.58%
ROICexc growth 3Y10.68%
ROICexc growth 5Y17.17%
OM growth 3Y6.94%
OM growth 5Y17.14%
PM growth 3Y-13.42%
PM growth 5Y51.49%
GM growth 3Y6.26%
GM growth 5Y8.78%
F-Score5
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 113.79%
Cap/Sales 0.65%
Interest Coverage 250
Cash Conversion 122.64%
Profit Quality 89.24%
Current Ratio 4.26
Quick Ratio 4.26
Altman-Z 7.1
F-Score5
WACC8.75%
ROIC/WACC1.83
Cap/Depr(3y)179.46%
Cap/Depr(5y)167.67%
Cap/Sales(3y)0.93%
Cap/Sales(5y)0.78%
Profit Quality(3y)87.69%
Profit Quality(5y)95.22%
High Growth Momentum
Growth
EPS 1Y (TTM)82.81%
EPS 3Y-1.83%
EPS 5Y61.08%
EPS Q2Q%50.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.35%
Revenue growth 3Y18.15%
Revenue growth 5Y15.18%
Sales Q2Q%20.64%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.82%
EBIT growth 3Y26.35%
EBIT growth 5Y34.93%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y126.55%
FCF growth 3Y10.69%
FCF growth 5Y4.68%
OCF growth 1Y121.68%
OCF growth 3Y11.03%
OCF growth 5Y4.91%

COMSTOCK HOLDING COMPANIES / CHCI FAQ

Can you provide the ChartMill fundamental rating for COMSTOCK HOLDING COMPANIES?

ChartMill assigns a fundamental rating of 7 / 10 to CHCI.


Can you provide the valuation status for COMSTOCK HOLDING COMPANIES?

ChartMill assigns a valuation rating of 5 / 10 to COMSTOCK HOLDING COMPANIES (CHCI). This can be considered as Fairly Valued.


What is the profitability of CHCI stock?

COMSTOCK HOLDING COMPANIES (CHCI) has a profitability rating of 9 / 10.


What is the financial health of COMSTOCK HOLDING COMPANIES (CHCI) stock?

The financial health rating of COMSTOCK HOLDING COMPANIES (CHCI) is 9 / 10.